Clinical Trial Update: 11ß-HSD1 and Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update on 11ß-HSD1 inhibitors in metabolic syndrome and impaired glucose tolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Metabolic Syndrome

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Metabolic Syndrome, Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED